Literature DB >> 20224454

Alpha-synuclein deficient mice are resistant to toxin-induced multiple system atrophy.

Kiren Ubhi1, Edward Rockenstein, Michael Mante, Chandra Inglis, Anthony Adame, Christina Patrick, Eliezer Masliah.   

Abstract

Multiple systems atrophy (MSA) is a neurodegenerative disorder characterized by oligodendrocytic accumulations of alpha-synuclein (alphasyn). Oxidative stress is a key mechanism proposed to underlie MSA pathology. To address the role of alphasyn modifications, over and above general oxidative modifications, this study examined the effects of 3-nitropropionic acid (3NP) administration, a technique used to model MSA, in knock-out mice lacking alphasyn (alphasynKO). Although susceptible to 3NP-induced oxidative stress, alphasynKO mice display reduced neuronal loss and dendritic pathology. The alphasynKO mice are resistant to 3NP-induced motor deficits and display attenuated loss of tyrosine hydroxylase and dopamine transporter striatal immunoreactivity. The results suggest that deficits in MSA are not due to general oxidative protein modification but in addition may be related to specific alphasyn modifications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20224454      PMCID: PMC3049936          DOI: 10.1097/WNR.0b013e328338ba6b

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  22 in total

1.  Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.

Authors:  Robert E Drolet; Bahareh Behrouz; Keith J Lookingland; John L Goudreau
Journal:  Neurotoxicology       Date:  2004-09       Impact factor: 4.294

2.  Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP.

Authors:  William Dauer; Nikolai Kholodilov; Miquel Vila; Anne-Cecile Trillat; Rose Goodchild; Kristin E Larsen; Roland Staal; Kim Tieu; Yvonne Schmitz; Chao Annie Yuan; Marcelo Rocha; Vernice Jackson-Lewis; Steven Hersch; David Sulzer; Serge Przedborski; Robert Burke; Rene Hen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-10       Impact factor: 11.205

3.  Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.

Authors:  B I Giasson; J E Duda; I V Murray; Q Chen; J M Souza; H I Hurtig; H Ischiropoulos; J Q Trojanowski; V M Lee
Journal:  Science       Date:  2000-11-03       Impact factor: 47.728

4.  Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein.

Authors:  Sheila M Fleming; Jonathan Salcedo; Pierre-Olivier Fernagut; Edward Rockenstein; Eliezer Masliah; Michael S Levine; Marie-Françoise Chesselet
Journal:  J Neurosci       Date:  2004-10-20       Impact factor: 6.167

5.  Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy.

Authors:  Akio Kikuchi; Atsushi Takeda; Hiroshi Onodera; Teiko Kimpara; Kinya Hisanaga; Nobuyuki Sato; Akihiko Nunomura; Rudy J Castellani; George Perry; Mark A Smith; Yasuto Itoyama
Journal:  Neurobiol Dis       Date:  2002-03       Impact factor: 5.996

Review 6.  Oxidative modifications of alpha-synuclein.

Authors:  Harry Ischiropoulos
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

7.  Effects of oxidative and nitrative challenges on alpha-synuclein fibrillogenesis involve distinct mechanisms of protein modifications.

Authors:  Erin H Norris; Benoit I Giasson; Harry Ischiropoulos; Virginia M-Y Lee
Journal:  J Biol Chem       Date:  2003-05-08       Impact factor: 5.157

8.  Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice.

Authors:  Darren C Robertson; Oliver Schmidt; Natalia Ninkina; Paul A Jones; John Sharkey; Vladimir L Buchman
Journal:  J Neurochem       Date:  2004-06       Impact factor: 5.372

9.  Mitochondrial inhibitor 3-nitroproprionic acid enhances oxidative modification of alpha-synuclein in a transgenic mouse model of multiple system atrophy.

Authors:  Kiren Ubhi; Phil Hyu Lee; Anthony Adame; Chandra Inglis; Michael Mante; Edward Rockenstein; Nadia Stefanova; Gregor K Wenning; Eliezer Masliah
Journal:  J Neurosci Res       Date:  2009-09       Impact factor: 4.164

10.  Environmental-occupational risk factors and familial associations in multiple system atrophy: a preliminary investigation.

Authors:  L E Nee; M R Gomez; J Dambrosia; S Bale; R Eldridge; R J Polinsky
Journal:  Clin Auton Res       Date:  1991-03       Impact factor: 4.435

View more
  10 in total

Review 1.  Multiple system atrophy: a clinical and neuropathological perspective.

Authors:  Kiren Ubhi; Phillip Low; Eliezer Masliah
Journal:  Trends Neurosci       Date:  2011-09-29       Impact factor: 13.837

2.  Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection.

Authors:  Venkatramanujam Srinivasan; Daniel P Cardinali; Uddanapalli S Srinivasan; Charanjit Kaur; Gregory M Brown; D Warren Spence; Rüdiger Hardeland; Seithikurippu R Pandi-Perumal
Journal:  Ther Adv Neurol Disord       Date:  2011-09       Impact factor: 6.570

3.  LIMP-2 expression is critical for β-glucocerebrosidase activity and α-synuclein clearance.

Authors:  Michelle Rothaug; Friederike Zunke; Joseph R Mazzulli; Michaela Schweizer; Hermann Altmeppen; Renate Lüllmann-Rauch; Wouter W Kallemeijn; Paulo Gaspar; Johannes M Aerts; Markus Glatzel; Paul Saftig; Dimitri Krainc; Michael Schwake; Judith Blanz
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-14       Impact factor: 11.205

4.  Multiple system atrophy: current and future approaches to management.

Authors:  Olivier Flabeau; Wassilios G Meissner; François Tison
Journal:  Ther Adv Neurol Disord       Date:  2010-07       Impact factor: 6.570

5.  Reducing Endogenous α-Synuclein Mitigates the Degeneration of Selective Neuronal Populations in an Alzheimer's Disease Transgenic Mouse Model.

Authors:  Brian Spencer; Paula A Desplats; Cassia R Overk; Elvira Valera-Martin; Robert A Rissman; Chengbiao Wu; Michael Mante; Anthony Adame; Jazmin Florio; Edward Rockenstein; Eliezer Masliah
Journal:  J Neurosci       Date:  2016-07-27       Impact factor: 6.167

Review 6.  Multiple system atrophy: pathogenic mechanisms and biomarkers.

Authors:  Kurt A Jellinger; Gregor K Wenning
Journal:  J Neural Transm (Vienna)       Date:  2016-04-20       Impact factor: 3.575

7.  Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo.

Authors:  Edward Rockenstein; Silke Nuber; Cassia R Overk; Kiren Ubhi; Michael Mante; Christina Patrick; Anthony Adame; Margarita Trejo-Morales; Juan Gerez; Paola Picotti; Poul H Jensen; Silvia Campioni; Roland Riek; Jürgen Winkler; Fred H Gage; Beate Winner; Eliezer Masliah
Journal:  Brain       Date:  2014-03-24       Impact factor: 13.501

8.  A novel triple repeat mutant tau transgenic model that mimics aspects of pick's disease and fronto-temporal tauopathies.

Authors:  Edward Rockenstein; Cassia R Overk; Kiren Ubhi; Michael Mante; Christina Patrick; Anthony Adame; Alejandro Bisquert; Margarita Trejo-Morales; Brian Spencer; Eliezer Masliah
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

Review 9.  Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?

Authors:  Benjamin Ettle; Johannes C M Schlachetzki; Jürgen Winkler
Journal:  Mol Neurobiol       Date:  2015-05-13       Impact factor: 5.590

Review 10.  Towards translational therapies for multiple system atrophy.

Authors:  Daniela Kuzdas-Wood; Nadia Stefanova; Kurt A Jellinger; Klaus Seppi; Michael G Schlossmacher; Werner Poewe; Gregor K Wenning
Journal:  Prog Neurobiol       Date:  2014-03-02       Impact factor: 11.685

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.